Q3 Investor Presentation COVID-19
Filed with ASX · · 23 pages · English
Prof. Rob Phillips PhD(Med), MPhil(Med), FASE, DMU(Cardiol) Chairman, CEO, Chief Scientist, Uscom Limited, Sydney, Australia Critical Care Research Group, School of Medicine, The University of Queensland, Brisbane, Australia OVERVIEW COVID-19 and Uscom, treatment and international guidelines Uscom Overview Mission, Products, People Company Introduction Uscom Q3 Results devices Strategy, investment
In the deck
Earlier from Uscom
- Uscom Investor Update - Coronavirus
- USCOM 1A in New International Sepsis Guidelines for Children
- Response to ASX Aware Query
- Reinstatement to Official Quotation
- Clarification-Material increase in USCOM 1A orders in China
Later from Uscom
- Uscom Partners with UTAS in IDEAL eHealth Initiative
- Uscom Partners with AD for BP Plus New Advanced Modules
- Q4 Briefing 2020
- Quarterly Activities Report - June 2020
- FY2020 Q4 Investor Briefing
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom